Press Release from

Saxon-Chinese stem cell bank set up

Vita 34 enters into collaboration with Chinese partner on clinical studies

Leipzig, 8 May 2017. On the first day of the trade mission led by environment minister Thomas Schmidt, Vita 34 AG from Leipzig has signed an important agreement in the Northern Chinese city of Yinchuan. Vita 34 is going to collaborate with the Chinese company AVIC Biology in the research on clinical studies related to drug licensing in China and Europe. The agreement was signed in the presence of Mayor Baichun Guo at the town hall of Yinchuan in the evening.

The collaboration is another building block in the partnership of both companies which is to be perfected by establishing a Saxon-Chinese joint venture. Then, stem cell storage will start in Yinchuan.

“The joint technology venture will provide for a cord blood bank offering the highest quality standards in China in the future”, says Minister Schmidt. “This project shows that the expertise and experience of Vita 34 AG as a specialist in the storage of stem cells from the umbilical cord is in great demand all over the world. I want the collaboration to develop successfully for both partners.”

Vita 34 AG will supply the know-how for establishing a cord blood bank for stem cells. This comprises technical counselling as well as qualifying the Chinese staff. Dr. André Gerth, CEO of Vita 34 AG, has been preparing the collaboration for two years now: “It is an important step for us on the way to further internationalization of our business. We found a competent partner in AVIC Biology to master even such a comprehensive project. Through the collaboration on the clinical field, we want to develop a stem cell therapeutic agent that will get licensed in China and in Europe.”